MIPS - Quality Measures

Advancing Care Information Measures
Improvement Activities Measures


Measure ID Title eMeasure ID Measure Type NQF ID High Priority Submission Methods Risk Adjusted? Registry Measure?
442 Persistence of Beta-Blocker Treatment After a Heart Attack Process 0071 Registry
007 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%) CMS145v5 Process 0070 Electronic Health Record | Registry
065 Appropriate Treatment for Children with Upper Respiratory Infection (URI) CMS154v5 Process 0069 Electronic Health Record | Registry
204 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet CMS164v5 Process 0068 Claims | Electronic Health Record | Cms Web Interface | Registry
006 Coronary Artery Disease (CAD): Antiplatelet Therapy Process 0067 Registry
118 Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) Process 0066 Registry
119 Diabetes: Medical Attention for Nephropathy CMS134v5 Process 0062 Electronic Health Record | Registry
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) CMS122v5 Intermediate Outcome 0059 Claims | Cms Web Interface | Electronic Health Record | Registry
116 Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis Process 0058 Registry
163 Diabetes: Foot Exam CMS123v5 Process 0056 Electronic Health Record
dmComposite Diabetes Mellitus (DM) Composite (All or Nothing Scoring) Intermediate Outcome And Process 0055 & 0059 Cms Web Interface
117 Diabetes: Eye Exam CMS131v5 Process 0055 Claims | Cms Web Interface | Electronic Health Record | Registry

Page 10 of 75